Lin Yu, Du Wenyu, Fu Xiangyu, Huang Ling, Hong Yiwen, Tan Haishan, Xiao Lirong, Ren Xiang, Wang Yujiao, Chen Danian
Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Research Laboratory of Ophthalmology and Vision Sciences, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Front Pharmacol. 2024 Jul 23;15:1395887. doi: 10.3389/fphar.2024.1395887. eCollection 2024.
Chemicals, such as MNU (N-methyl-N-nitrosourea) and NaIO3 (sodium iodate), are widely used to induce retinal degeneration in rodents. Streptozotocin (STZ) is an analog of N-acetyl glucosamine in which an MNU moiety is linked to a hexose and has a special toxic effect on insulin-producing pancreatic β-cells. It is commonly used to induce hyperglycemia to model diabetes. While intracerebroventricular injection of STZ can produce Alzheimer's disease independent of hyperglycemia, most retinal studies using STZ focus on the effects of hyperglycemia on the retina, but whether STZ has any impact on retinal cells independent of hyperglycemia is unknown. We aimed to investigate the role of cytotoxicity of STZ in rat retina. Intravitreal or subcutaneous injection of STZ was performed on newborn rats. Electroretinogram (ERG) and H&E staining investigated retinal function and morphological changes. Retinal cell types, cell death, proliferation, inflammation, and angiogenesis were studied by immunostaining. RNA sequencing was performed to examine the transcriptome changes of retinal cells after intravitreal injection of STZ. Intravitreal (5 μg or 10 μg) or subcutaneous (30 mg/kg) injection of STZ at the early stage of newborn rats couldn't induce hyperglycemia but caused NSIR (Neonatal STZ-induced retinopathy), including reduced ERG amplitudes, retinal rosettes and apoptosis, cell cycle arrest, microglial activation, and delayed retinal angiogenesis. STZ did not affect the early-born retinal cell types but significantly reduced the late-born ones. Short-term and long-term hyperglycemia had no significant effects on the NSIR phenotypes. RNA sequencing revealed that STZ induces oxidative stress and activates the p53 pathway of retinal cells. Locally or systemically, STZ injection after P8 couldn't induce SINR when all retinal progenitors exit the cell cycle. NSIR in rats is independent of hyperglycemia but due to STZ's direct cytotoxic effects on retinal progenitor cells. NSIR is a typical reaction to STZ-induced retinal oxidative stress and DNA damage. This significant finding suggests that NSIR may be a valuable model for studying retinal progenitor DNA damage-related diseases, potentially leading to new insights and treatments.
化学物质,如N-甲基-N-亚硝基脲(MNU)和碘酸钠(NaIO₃),被广泛用于诱导啮齿动物视网膜变性。链脲佐菌素(STZ)是N-乙酰葡糖胺的类似物,其中MNU部分与己糖相连,对产生胰岛素的胰腺β细胞具有特殊毒性作用。它通常用于诱导高血糖以模拟糖尿病。虽然脑室内注射STZ可独立于高血糖产生阿尔茨海默病,但大多数使用STZ的视网膜研究集中于高血糖对视网膜的影响,但是STZ是否独立于高血糖对视网膜细胞有任何影响尚不清楚。我们旨在研究STZ的细胞毒性在大鼠视网膜中的作用。对新生大鼠进行玻璃体内或皮下注射STZ。通过视网膜电图(ERG)和苏木精-伊红(H&E)染色研究视网膜功能和形态变化。通过免疫染色研究视网膜细胞类型、细胞死亡、增殖、炎症和血管生成。进行RNA测序以检查玻璃体内注射STZ后视网膜细胞的转录组变化。在新生大鼠早期进行玻璃体内(5μg或10μg)或皮下(30mg/kg)注射STZ不会诱导高血糖,但会导致新生儿STZ诱导的视网膜病变(NSIR),包括ERG振幅降低、视网膜玫瑰花结和细胞凋亡、细胞周期停滞、小胶质细胞活化以及视网膜血管生成延迟。STZ不影响早期出生的视网膜细胞类型,但显著减少晚期出生的细胞类型。短期和长期高血糖对NSIR表型无显著影响。RNA测序显示STZ诱导氧化应激并激活视网膜细胞的p53途径。当所有视网膜祖细胞退出细胞周期后,在出生后第8天(P8)进行局部或全身STZ注射不能诱导新生儿STZ诱导的视网膜病变(SINR)。大鼠中的NSIR独立于高血糖,而是由于STZ对视网膜祖细胞的直接细胞毒性作用。NSIR是对STZ诱导的视网膜氧化应激和DNA损伤的典型反应。这一重要发现表明,NSIR可能是研究视网膜祖细胞DNA损伤相关疾病的有价值模型,可能会带来新的见解和治疗方法。